Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Loreana Gallo, Marcos Andrés Serain, Carlos Renaudo, Eduardo López & Verónica Bucalá. (2022) Influence of microbubbles on the production of spray-dried inhalable particles. Drying Technology 40:9, pages 1819-1831.
Read now
Read now
Sagar Pardeshi, Mahesh More, Pritam Patil, Chandrakantsing Pardeshi, Prashant Deshmukh, Arun Mujumdar & Jitendra Naik. (2021) A meticulous overview on drying-based (spray-, freeze-, and spray-freeze) particle engineering approaches for pharmaceutical technologies. Drying Technology 39:11, pages 1447-1491.
Read now
Read now
Rachel Yoon Kyung Chang, Lan Chen, Donghao Chen & Hak-Kim Chan. (2020) Overcoming challenges for development of amorphous powders for inhalation. Expert Opinion on Drug Delivery 17:11, pages 1583-1595.
Read now
Read now
Keith T. Ung, Nagaraja Rao, Jeffry G. Weers, Andrew R. Clark & Hak-Kim Chan. (2014) In Vitro Assessment of Dose Delivery Performance of Dry Powders for Inhalation. Aerosol Science and Technology 48:10, pages 1099-1110.
Read now
Read now
Tomás Sou, MichelleP. McIntosh, LisaM. Kaminskas, RichardJ. Prankerd & DavidA. V. Morton. (2013) Designing a Multicomponent Spray-Dried Formulation Platform for Pulmonary Delivery of Biomacromolecules: The Effect of Polymers on the Formation of an Amorphous Matrix for Glassy State Stabilization of Biomacromolecules. Drying Technology 31:13-14, pages 1451-1458.
Read now
Read now
Hiroyuki Ohbayashi & Mitsuru Adachi. (2012) Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD. International Journal of General Medicine 5, pages 517-524.
Read now
Read now
Zhen Xu, HeidiM. Mansour & AnthonyJ. Hickey. (2011) Particle Interactions in Dry Powder Inhaler Unit Processes: A Review. Journal of Adhesion Science and Technology 25:4-5, pages 451-482.
Read now
Read now
Jonathan B. Tucker. (2008) The body's own bioweapons. Bulletin of the Atomic Scientists 64:1, pages 16-57.
Read now
Read now
Articles from other publishers (88)
Yuqing Ye, Tingting Shi, Ziyi Fan, Chenjia Bai, Ying Ma & Jesse Zhu. (2023) Elucidation of the using condition and working mechanism of tertiary lactose in dry powder formulations for inhalation. Powder Technology 427, pages 118709.
Crossref
Crossref
Sara Ahmed, Mai Mansour, Rania A.H. Ishak & Nahed D. Mortada. (2023) Customizable resveratrol spray-dried micro-composites for inhalation as a promising contender for treatment of idiopathic pulmonary fibrosis. International Journal of Pharmaceutics 642, pages 123117.
Crossref
Crossref
Xiyue He, Xiaoyan Chen, Hairui Wang, Guangsheng Du & Xun Sun. (2023) Recent advances in respiratory immunization: A focus on COVID-19 vaccines. Journal of Controlled Release 355, pages 655-674.
Crossref
Crossref
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines
531
589
.
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines
325
530
.
Myla Manser, Blair A. Morgan, Xueya Feng, Rod G. Rhem, Myrna B. Dolovich, Zhou Xing, Emily D. Cranston & Michael R. Thompson. (2022) Dextran Mass Ratio Controls Particle Drying Dynamics in a Thermally Stable Dry Powder Vaccine for Pulmonary Delivery. Pharmaceutical Research 39:9, pages 2315-2328.
Crossref
Crossref
Mina Mehanny, Annette Boese, Behnoosh Bornamehr, Jessica Hoppstädter, Volker Presser, Alexandra K. Kiemer, Claus-Michael Lehr & Gregor Fuhrmann. (2022) Spray-dried pneumococcal membrane vesicles are promising candidates for pulmonary immunization. International Journal of Pharmaceutics 621, pages 121794.
Crossref
Crossref
Andrew R. Clark. (2022) Half a Century of Technological Advances in Pulmonary Drug Delivery: A Personal Perspective. Frontiers in Drug Delivery 2.
Crossref
Crossref
Meng-jie Sun, Zhuang Teng, Peng-sheng Fan, Xi-guang Chen & Ya Liu. (2022) Bridging micro/nano-platform and airway allergy intervention. Journal of Controlled Release 341, pages 364-382.
Crossref
Crossref
Heejun Park, Eun-Sol Ha & Min-Soo Kim. (2021) Surface modification strategies for high-dose dry powder inhalers. Journal of Pharmaceutical Investigation 51:6, pages 635-668.
Crossref
Crossref
Blair A. Morgan, Elina Niinivaara, Zhou Xing, Michael R. Thompson & Emily D. Cranston. (2021) Validation of a diffusion-based single droplet drying model for encapsulation of a viral-vectored vaccine using an acoustic levitator. International Journal of Pharmaceutics 605, pages 120806.
Crossref
Crossref
Basanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, Robin Polt & Heidi M. Mansour. (2021) Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides. AAPS PharmSciTech 22:5.
Crossref
Crossref
Prakash Khadka, Shubhra Sinha, Ian G. Tucker, Jack Dummer, Philip C. Hill, Rajesh Katare & Shyamal C. Das. (2021) Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats. European Journal of Pharmaceutics and Biopharmaceutics 162, pages 1-11.
Crossref
Crossref
Peter Hoogevest, Harry Tiemessen, Josbert M. Metselaar, Simon Drescher & Alfred Fahr. (2021) The Use of Phospholipids to Make Pharmaceutical Form Line Extensions. European Journal of Lipid Science and Technology 123:4, pages 2000297.
Crossref
Crossref
Tomás Sou & Christel A.S. Bergström. (2021) Contemporary Formulation Development for Inhaled Pharmaceuticals. Journal of Pharmaceutical Sciences 110:1, pages 66-86.
Crossref
Crossref
Hana Douafer, Véronique Andrieu & Jean Michel Brunel. (2020) Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases. Journal of Controlled Release 325, pages 276-292.
Crossref
Crossref
Reinhard Vehring, Herm Snyder & David Lechuga‐Ballesteros. 2020. Drying Technologies for Biotechnology and Pharmaceutical Applications. Drying Technologies for Biotechnology and Pharmaceutical Applications
179
216
.
Andrew R. ClarkJeffry G. WeersRajiv Dhand. (2020) The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates. Journal of Aerosol Medicine and Pulmonary Drug Delivery 33:1, pages 1-11.
Crossref
Crossref
Omar A. Elkady, Mina Ibrahim Tadros & Hanan M. El-laithy. (2019) QbD Approach for Novel Crosslinker-Free Ionotropic Gelation of Risedronate Sodium–Chitosan Nebulizable Microspheres: Optimization and Characterization. AAPS PharmSciTech 21:1.
Crossref
Crossref
Roxane Abdel-Gawad, Rihab Osman, Gehanne A.S. Awad & Nahed Mortada. (2020) Lecithin-based modified soft agglomerate composite microparticles for inhalable montelukast: Development, tolerability and pharmacodynamic activity. Powder Technology 360, pages 1167-1176.
Crossref
Crossref
Yang Li & Daniel S. Kohane. 2020. Biomaterials Science. Biomaterials Science
431
451
.
Elia Bari, Ilaria Ferrarotti, Maria Luisa Torre, Angelo Guido Corsico & Sara Perteghella. (2019) Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. Journal of Controlled Release 309, pages 11-24.
Crossref
Crossref
Hend I. Shahin, Bhavani Prasad Vinjamuri, Azza A. Mahmoud, Rehab N. Shamma, Suzan M. Mansour, Hussein O. Ammar, Mahmoud M. Ghorab, Mahavir Bhupal Chougule & Lipika Chablani. (2019) Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension. Journal of Controlled Release 302, pages 126-139.
Crossref
Crossref
S. Focaroli, P.T. Mah, J.E. Hastedt, I. Gitlin, S. Oscarson, J.V. Fahy & A.M. Healy. (2019) A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery. International Journal of Pharmaceutics 562, pages 228-240.
Crossref
Crossref
Jeffry G. WeersYoen-Ju SonMark GluskerAlfred HaynesDaniel HuangNani KadrichuJohn LeXue LiRichard MalcolmsonDanforth P. MillerThomas E. TararaKeith UngAndy Clark. (2019) Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?. Journal of Aerosol Medicine and Pulmonary Drug Delivery 32:2, pages 55-69.
Crossref
Crossref
Yu-Jung Lin, Fwu-Long Mi, Po-Yen Lin, Yang-Bao Miao, Tringyo Huang, Kuan-Hung Chen, Chiung-Tong Chen, Yen Chang & Hsing-Wen Sung. (2019) Strategies for improving diabetic therapy via alternative administration routes that involve stimuli-responsive insulin-delivering systems. Advanced Drug Delivery Reviews 139, pages 71-82.
Crossref
Crossref
Jun Yee Tse, Kazunori Kadota, Yoshiyuki Hirata, Masahiko Taniguchi, Hiromasa Uchiyama & Yuichi Tozuka. (2018) Characterization of matrix embedded formulations for combination spray-dried particles comprising pyrazinamide and rifampicin. Journal of Drug Delivery Science and Technology 48, pages 137-144.
Crossref
Crossref
Dalia M. Kabary, Maged W. Helmy, Elsayeda-Zeinab A. Abdelfattah, Jia-You Fang, Kadria A. Elkhodairy & Ahmed O. Elzoghby. (2018) Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma. European Journal of Pharmaceutics and Biopharmaceutics 130, pages 152-164.
Crossref
Crossref
Nagaraja Rao, Brian Ament, Richard Parmee, Jonathan Cameron & Martin Mayo. (2018) Rapid, Non-destructive Inspection and Classification of Inhalation Blisters Using Low-Energy X-ray Imaging. Journal of Pharmaceutical Innovation 13:3, pages 270-282.
Crossref
Crossref
Conor A. RuzyckiAndrew R. MartinReinhard VehringWarren H. Finlay. (2018)
An
In Vitro
Examination of the Effects of Altitude on Dry Powder Inhaler Performance
. Journal of Aerosol Medicine and Pulmonary Drug Delivery 31:4, pages 221-236.
Crossref
Crossref
Rajeev Ranjan, Ashish Srivastava, Reena Bharti, Lipika Ray, Jyotsna Singh & Amit Misra. (2018) Preparation and optimization of a dry powder for inhalation of second-line anti-tuberculosis drugs. International Journal of Pharmaceutics 547:1-2, pages 150-157.
Crossref
Crossref
Duy Nguyen, Johan Remmelgas, Ingela Niklasson Björn, Berend van Wachem & Kyrre Thalberg. (2018) Towards quantitative prediction of the performance of dry powder inhalers by multi-scale simulations and experiments. International Journal of Pharmaceutics 547:1-2, pages 31-43.
Crossref
Crossref
Ashlee D. Brunaugh & Hugh D.C. Smyth. (2018) Formulation techniques for high dose dry powders. International Journal of Pharmaceutics 547:1-2, pages 489-498.
Crossref
Crossref
V. Carli, L. Menu-Bouaouiche, P. Cardinael, L. Benissan & G. Coquerel. (2018) Immunoglobulin G particles manufacturing by spray drying process for pressurised metered dose inhaler formulations. Annales Pharmaceutiques Françaises 76:4, pages 291-298.
Crossref
Crossref
Alejandro Nieto-Orellana, David Coghlan, Malcolm Rothery, Franco H. Falcone, Cynthia Bosquillon, Nick Childerhouse, Giuseppe Mantovani & Snow Stolnik. (2018) Dry-powder formulations of non-covalent protein complexes with linear or miktoarm copolymers for pulmonary delivery. International Journal of Pharmaceutics 540:1-2, pages 78-88.
Crossref
Crossref
Rajiv Dhand. 2016. Advances in Pulmonary Drug Delivery. Advances in Pulmonary Drug Delivery
67
92
.
Jennifer Wong, Maurizio Ricci & Hak-Kim Chan. 2016. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Drug Delivery Systems for Tuberculosis Prevention and Treatment
161
196
.
Lan Chen, Tomoyuki Okuda, Xiang-Yun Lu & Hak-Kim Chan. (2016) Amorphous powders for inhalation drug delivery. Advanced Drug Delivery Reviews 100, pages 102-115.
Crossref
Crossref
Min Jae Kim & Jin-Hyun Kim. (2016) Decreasing Particle Size of Paclitaxel Using Polymer in Fractional Precipitation Process. Korean Chemical Engineering Research 54:2, pages 278-283.
Crossref
Crossref
Tomás Sou, Robert T. Forbes, Jason Gray, Richard J. Prankerd, Lisa M. Kaminskas, Michelle P. McIntosh & David A.V. Morton. (2016) Designing a multi-component spray-dried formulation platform for pulmonary delivery of biopharmaceuticals: The use of polyol, disaccharide, polysaccharide and synthetic polymer to modify solid-state properties for glassy stabilisation. Powder Technology 287, pages 248-255.
Crossref
Crossref
Kazunori Kadota, Arisa Senda, Takuya Ito & Yuichi Tozuka. (2015) Feasibility of highly branched cyclic dextrin as an excipient matrix in dry powder inhalers. European Journal of Pharmaceutical Sciences 79, pages 79-86.
Crossref
Crossref
Tomás SouDavid A.V. MortonMark WilliamsonEls N. MeeusenLisa M. KaminskasMichelle P. McIntosh. (2015) Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration. Journal of Aerosol Medicine and Pulmonary Drug Delivery 28:5, pages 361-371.
Crossref
Crossref
Jeffry G. Weers & Danforth P. Miller. (2015) Formulation Design of Dry Powders for Inhalation. Journal of Pharmaceutical Sciences 104:10, pages 3259-3288.
Crossref
Crossref
Danforth P. Miller, Trixie Tan, Thomas E. Tarara, John Nakamura, Richard J. Malcolmson & Jeffry G. Weers. (2015) Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs. Molecular Pharmaceutics 12:8, pages 2582-2593.
Crossref
Crossref
Deepak J. SinghRajesh R. JainP. S. SoniSamad AbdulHegde DarshanaRajiv V. GaikwadMala D. Menon. (2015) Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery 28:4, pages 254-267.
Crossref
Crossref
Adam Bohr, Feng Wan, Jakob Kristensen, Mark Dyas, Eleanor Stride, Stefania Baldursdottír, Mohan Edirisinghe & Mingshi Yang. (2015) Pharmaceutical microparticle engineering with electrospraying: the role of mixed solvent systems in particle formation and characteristics. Journal of Materials Science: Materials in Medicine 26:2.
Crossref
Crossref
Emily P. Wen, Ronald Ellis & Narahari S. PujarSatoshi Ohtake, David Lechuga‐Ballesteros, Vu Truong‐Le & Eric J. Patzer. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing
287
318
.
Susan HoeMohammed A. BoraeyJames W. IveyWarren H. FinlayReinhard Vehring. (2014) Manufacturing and Device Options for the Delivery of Biotherapeutics. Journal of Aerosol Medicine and Pulmonary Drug Delivery 27:5, pages 315-328.
Crossref
Crossref
Naila A. Mugheirbi, Krzysztof J. Paluch & Lidia Tajber. (2014) Heat induced evaporative antisolvent nanoprecipitation (HIEAN) of itraconazole. International Journal of Pharmaceutics 471:1-2, pages 400-411.
Crossref
Crossref
Feng Wan, Morten Jonas Maltesen, Sune Klint Andersen, Simon Bjerregaard, Camilla Foged, Jukka Rantanen & Mingshi Yang. (2014) One-Step Production of Protein-Loaded PLGA Microparticles via Spray Drying Using 3-Fluid Nozzle. Pharmaceutical Research 31:8, pages 1967-1977.
Crossref
Crossref
Eike Cordts & Hartwig Steckel. (2014) Formulation considerations for dry powder inhalers. Therapeutic Delivery 5:6, pages 675-689.
Crossref
Crossref
Jatindra SahuChung Law, Wan Daud & Arun Mujumdar. 2014. Introduction to Advanced Food Process Engineering. Introduction to Advanced Food Process Engineering
31
78
.
Jeffry WeersThomas Tarara. (2014) The PulmoSphere™ platform for pulmonary drug delivery. Therapeutic Delivery 5:3, pages 277-295.
Crossref
Crossref
Susan Hoe, James W. Ivey, Mohammed A. Boraey, Abouzar Shamsaddini-Shahrbabak, Emadeddin Javaheri, Sadaf Matinkhoo, Warren H. Finlay & Reinhard Vehring. (2013) Use of a Fundamental Approach to Spray-Drying Formulation Design to Facilitate the Development of Multi-Component Dry Powder Aerosols for Respiratory Drug Delivery. Pharmaceutical Research 31:2, pages 449-465.
Crossref
Crossref
Mohammed A. Boraey & Reinhard Vehring. (2014) Diffusion controlled formation of microparticles. Journal of Aerosol Science 67, pages 131-143.
Crossref
Crossref
Sarah Claus, Claudius Weiler, Joerg Schiewe & Wolfgang Friess. (2014) How can we bring high drug doses to the lung?. European Journal of Pharmaceutics and Biopharmaceutics 86:1, pages 1-6.
Crossref
Crossref
Amit K. Goyal, Goutam Rath & Basant Malik. 2014. Molecular Vaccines. Molecular Vaccines
579
601
.
Anthony J. Hickey & Zhen Xu. 2014. Particulate Products. Particulate Products
295
322
.
Richard J. Prankerd, Tri-Hung Nguyen, Jibriil P. Ibrahim, Robert J. Bischof, Gemma C. Nassta, Livesey D. Olerile, Adrian S. Russell, Felix Meiser, Helena C. Parkington, Harold A. Coleman, David A. V. Morton & Michelle P. McIntosh. (2013) Pulmonary Delivery of an Ultra-Fine Oxytocin Dry Powder Formulation: Potential for Treatment of Postpartum Haemorrhage in Developing Countries. PLoS ONE 8:12, pages e82965.
Crossref
Crossref
Flore Depreter, Gabrielle Pilcer & Karim Amighi. (2013) Inhaled proteins: Challenges and perspectives. International Journal of Pharmaceutics 447:1-2, pages 251-280.
Crossref
Crossref
Jeffry WeersKeith UngJohn LeNagaraja RaoBrian AmentGeorge AxfordDavid MaltzLeo Chan. (2013)
Dose Emission Characteristics of Placebo PulmoSphere
®
Particles Are Unaffected by a Subject's Inhalation Maneuver
. Journal of Aerosol Medicine and Pulmonary Drug Delivery 26:1, pages 56-68.
Crossref
Crossref
Mohammed A. Boraey, Susan Hoe, Hajar Sharif, Danforth P. Miller, David Lechuga-Ballesteros & Reinhard Vehring. (2013) Improvement of the dispersibility of spray-dried budesonide powders using leucine in an ethanol–water cosolvent system. Powder Technology 236, pages 171-178.
Crossref
Crossref
Yoen-Ju Son, P. Worth Longest & Michael Hindle. (2013) Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: Effect of spray drying process conditions on aerosol performance. International Journal of Pharmaceutics 443:1-2, pages 137-145.
Crossref
Crossref
Tomás Sou, Lisa M. Kaminskas, Tri-Hung Nguyen, Renée Carlberg, Michelle P. McIntosh & David A.V. Morton. (2013) The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. European Journal of Pharmaceutics and Biopharmaceutics 83:2, pages 234-243.
Crossref
Crossref
David A. V. Morton. 2013. Inhalation Drug Delivery. Inhalation Drug Delivery
63
89
.
F. Wan, M.J. Maltesen, S. Bjerregaard, C. Foged, J. Rantanen & M. Yang. (2013) Particle engineering technologies for improving the delivery of peptide and protein drugs. Journal of Drug Delivery Science and Technology 23:4, pages 355-363.
Crossref
Crossref
Christophe Duret, Nathalie Wauthoz, Thami Sebti, Francis Vanderbist & Karim Amighi. (2012) New Respirable and Fast Dissolving Itraconazole Dry Powder Composition for the Treatment of Invasive Pulmonary Aspergillosis. Pharmaceutical Research 29:10, pages 2845-2859.
Crossref
Crossref
Qi (Tony) Zhou & David A.V. Morton. (2012) Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces. Advanced Drug Delivery Reviews 64:3, pages 275-284.
Crossref
Crossref
S. Al-Qadi, A. Grenha, D. Carrión-Recio, B. Seijo & C. Remuñán-López. (2012) Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations. Journal of Controlled Release 157:3, pages 383-390.
Crossref
Crossref
Alpana A. Thorat & Sameer V. Dalvi. (2012) Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspective. Chemical Engineering Journal 181-182, pages 1-34.
Crossref
Crossref
Tomás Sou, Laurence Orlando, Michelle P. McIntosh, Lisa M. Kaminskas & David A.V. Morton. (2011) Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach. International Journal of Pharmaceutics 421:2, pages 220-229.
Crossref
Crossref
Sadaf Matinkhoo, Karlene H. Lynch, Jonathan J. Dennis, Warren H. Finlay & Reinhard Vehring. (2011) Spray-dried Respirable Powders Containing Bacteriophages for the Treatment of Pulmonary Infections. Journal of Pharmaceutical Sciences 100:12, pages 5197-5205.
Crossref
Crossref
Martin J Donovan, Aileen Gibbons, Matthew J Herpin, Stephen Marek, Shayna L McGill & Hugh DC Smyth. (2011) Novel dry powder inhaler particle-dispersion systems. Therapeutic Delivery 2:10, pages 1295-1311.
Crossref
Crossref
David Lechuga-Ballesteros, Brian Noga, Reinhard Vehring, R Harris Cummings & Sarvajna K Dwivedi. (2011) Novel cosuspension metered-dose inhalers for the combination therapy of chronic obstructive pulmonary disease and asthma. Future Medicinal Chemistry 3:13, pages 1703-1718.
Crossref
Crossref
Libo Wu & Sandro R. P. da Rocha. (2011) Nanoparticle-Stabilized Colloids in Compressible Hydrofluoroalkanes. Langmuir 27:17, pages 10501-10506.
Crossref
Crossref
David E. GellerJeffry WeersSilvia Heuerding. (2011) Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology. Journal of Aerosol Medicine and Pulmonary Drug Delivery 24:4, pages 175-182.
Crossref
Crossref
Jian Zhang, Libo Wu, Hak-Kim Chan & Wiwik Watanabe. (2011) Formation, characterization, and fate of inhaled drug nanoparticles. Advanced Drug Delivery Reviews 63:6, pages 441-455.
Crossref
Crossref
Reinhard H. A. Becker. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
457
481
.
Zhen Xu & Anthony J. Hickey. 2011. Controlled Pulmonary Drug Delivery. Controlled Pulmonary Drug Delivery
75
100
.
Sheena H. Wang, Afton L. Thompson, Anthony J. Hickey & Herman F. Staats. 2012. Mucosal Vaccines. Mucosal Vaccines
121
156
.
Jeffry G. WeersJohn BellHak-Kim ChanDavid CipollaCraig DunbarAnthony J. HickeyIan J. Smith. (2010) Pulmonary Formulations: What Remains to be Done?. Journal of Aerosol Medicine and Pulmonary Drug Delivery 23:S2, pages S-5-S-23.
Crossref
Crossref
David CipollaHak-Kim Chan, Jeffrey Schuster & Dino Farina. (2010) Personalizing aerosol medicine: development of delivery systems tailored to the individual. Therapeutic Delivery 1:5, pages 667-682.
Crossref
Crossref
Ahmad M. Abdul-Fattah & Vu L. Truong. 2010. Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals. Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals
705
738
.
A. Grenha, S. Al-Qadi, B. Seijo & C. Remuñán-López. (2010) The potential of chitosan for pulmonary drug delivery. Journal of Drug Delivery Science and Technology 20:1, pages 33-43.
Crossref
Crossref
Richard S. Kaye, Tol S. Purewal & H. Oya Alpar. (2009) Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies. Journal of Pharmaceutical Sciences 98:11, pages 4055-4068.
Crossref
Crossref
Lihua Huang, P. Clayton Gough & Michael R. DeFelippis. (2008) Characterization of Poly(ethylene glycol) and PEGylated Products by LC/MS with Postcolumn Addition of Amines. Analytical Chemistry 81:2, pages 567-577.
Crossref
Crossref
Reinhard Vehring. (2007) Pharmaceutical Particle Engineering via Spray Drying. Pharmaceutical Research 25:5, pages 999-1022.
Crossref
Crossref
Paul A. Charpentier, Ming Jia & Rahima A. Lucky. (2008) Study of the RESS Process for Producing Beclomethasone-17,21-Dipropionate Particles Suitable for Pulmonary Delivery. AAPS PharmSciTech 9:1, pages 39-46.
Crossref
Crossref